The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The influence of cytokines on the complex pathology of ulcerative colitis
Open accessAbstract
Ulcerative colitis (UC) specifically affects the colon and rectum through multifactorial mechanisms associated with genetic alterations, environmental factors, microbiota, and mucosal immune dysregulation. In patients with corticosteroid-refractory UC, current therapies primarily employ antibodies against tumor necrosis factor-α, α4β7 integrin, and interleukin (IL)-12/23 p40; and a small-molecule Janus kinase inhibitor. Despite these revolutionary molecular targeting therapies introduced during the last two decades, 30%-55% of patients fail to respond such molecular targeting agents in the induction phase, requiring changes in treatment. Here we review basic and clinical research aimed to address this problem, focusing on the pathogenic effects of cytokines produced by innate and adaptive immune cells. For example, IL-1β, IL-6, tumor necrosis factor-α, T helper (Th) 1-, Th2-, and Th17-associated cytokines are expressed at relatively higher levels in the intestinal tissues of patients with UC. However, their expression levels depend on disease stage and patient characteristics. The complex pathology of UC may induce differences in responses to therapy. The findings of such studies strongly support the argument that future targeted therapies must focus on differences in cytokine levels associated with the stages of UC as well as on the distinct cytokine expression profiles of individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Kobayashi, T., Siegmund, B., Le Berre, C., Wei, S. C., Ferrante, M., Shen, B., Bernstein, C. N., Danese, S., Peyrin-Biroulet, L., & Hibi, T. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0205-x · Cited by 1,649
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Glocker, E.-O., Kotlarz, D., Boztug, K., Gertz, E. M., Schäffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., Allroth, A., Murugan, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907206 · Cited by 1,461
Sandborn, W. J., van Assche, G., Reinisch, W., Colombel, J., D’Haens, G., Wolf, D. C., Kron, M., Tighe, M. B., Lazar, A., & Thakkar, R. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.032 · Cited by 1,269
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Sands, B. E., Sandborn, W. J., Panaccione, R., O’Brien, C. D., Zhang, H., Johanns, J., Adedokun, O. J., Li, K., Peyrin-Biroulet, L., Van Assche, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900750 · Cited by 1,219
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017) · Drugs · doi:10.1007/s40265-017-0701-9 · Cited by 1,206
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Innate and adaptive immunity in inflammatory bowel disease
Geremia, A., Biancheri, P., Allan, P., Corazza, G. R., & Di Sabatino, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.06.004 · Cited by 982
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J.-F., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 940
Reinisch, W., Sandborn, W. J., Hommes, D. W., D'Haens, G., Hanauer, S., Schreiber, S., Panaccione, R., Fedorak, R. N., Tighe, M. B., Huang, B., et al. (2011) · Gut · doi:10.1136/gut.2010.221127 · Cited by 892
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Host–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis
Alex, P., Zachos, N. C., Nguyen, T., Gonzales, L., Chen, T.-E., Conklin, L. S., Centola, M., & Li, X. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20753 · Cited by 750
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Neurath, M. F. (2019) · Nature Immunology · doi:10.1038/s41590-019-0415-0 · Cited by 701
Martini, E., Krug, S. M., Siegmund, B., Neurath, M. F., & Becker, C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.007 · Cited by 668
New IBD genetics: common pathways with other diseases
Lees, C. W., Barrett, J. C., Parkes, M., & Satsangi, J. (2011) · Gut · doi:10.1136/gut.2009.199679 · Cited by 635
IL-23 and Th17 Cells Enhance Th2-Cell–mediated Eosinophilic Airway Inflammation in Mice
Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S.-I., Suto, A., Watanabe, N., Saito, Y., Hatano, M., Tokuhisa, T., Iwakura, Y., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-086oc · Cited by 437
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
Arijs, I., Li, K., Toedter, G., Quintens, R., Van Lommel, L., Van Steen, K., Leemans, P., De Hertogh, G., Lemaire, K., Ferrante, M., et al. (2009) · Gut · doi:10.1136/gut.2009.178665 · Cited by 408
Somatic inflammatory gene mutations in human ulcerative colitis epithelium
Nanki, K., Fujii, M., Shimokawa, M., Matano, M., Nishikori, S., Date, S., Takano, A., Toshimitsu, K., Ohta, Y., Takahashi, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1844-5 · Cited by 325
Ding, N. S., Hart, A., & De Cruz, P. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13445 · Cited by 309
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
Kakiuchi, N., Yoshida, K., Uchino, M., Kihara, T., Akaki, K., Inoue, Y., Kawada, K., Nagayama, S., Yokoyama, A., Yamamoto, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1856-1 · Cited by 256
Self-citationAnti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
Castro-Dopico, T., Dennison, T. W., Ferdinand, J. R., Mathews, R. J., Fleming, A., Clift, D., Stewart, B. J., Jing, C., Strongili, K., Labzin, L. I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.006 · Cited by 248
Feagan, B. G., Rubin, D. T., Danese, S., Vermeire, S., Abhyankar, B., Sankoh, S., James, A., & Smyth, M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.044 · Cited by 229
Mizoguchi, A., Mizoguchi, E., Chiba, C., Spiekermann, G. M., Tonegawa, S., Nagler-Anderson, C., & Bhan, A. K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.847 · Cited by 219
Distinct inflammatory mechanisms mediate early versus late colitis in mice
Spencer, D. M., Veldman, G. M., Banerjee, S., Willis, J., & Levine, A. D. (2002) · Gastroenterology · doi:10.1053/gast.2002.30308 · Cited by 209
Regulation of Antitumor Immune Responses by the IL‐12 Family Cytokines, IL‐12, IL‐23, and IL‐27
Xu, M., Mizoguchi, I., Morishima, N., Chiba, Y., Mizuguchi, J., & Yoshimoto, T. (2010) · Journal of Immunology Research · doi:10.1155/2010/832454 · Cited by 203
Cytokines in inflammatory bowel diseases – Update 2020
Leppkes, M., & Neurath, M. F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104835 · Cited by 192
Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Thomas, S., & Baumgart, D. C. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0104-6 · Cited by 191
Immunohistochemical Characterization of Local Immunoglobulin Formation in Ulcerative Colitis
Brandtzaeg, P., Baklien, K., Fausa, O., & Noel, P. S. (1974) · Gastroenterology · doi:10.1016/s0016-5085(74)80004-1 · Cited by 185
Muthas, D., Reznichenko, A., Balendran, C. A., Böttcher, G., Clausen, I. G., Kärrman Mårdh, C., Ottosson, T., Uddin, M., MacDonald, T. T., Danese, S., et al. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1235224 · Cited by 178
Genetics of inflammatory bowel disease: beyond NOD2
Mirkov, M. U., Verstockt, B., & Cleynen, I. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30111-x · Cited by 171
Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation
Bamias, G., Martin, C., Mishina, M., Ross, W. G., Rivera-Nieves, J., Marini, M., & Cominelli, F. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.053 · Cited by 166
Suzuki, Y., Motoya, S., Hanai, H., Matsumoto, T., Hibi, T., Robinson, A. M., Mostafa, N. M., Chao, J., Arora, V., Camez, A., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-013-0922-y · Cited by 164
IBD Candidate Genes and Intestinal Barrier Regulation
McCole, D. F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000090 · Cited by 161
D’Haens, G., & van Deventer, S. J. H. (2021) · Gut · doi:10.1136/gutjnl-2019-320022 · Cited by 157
Healing of intestinal inflammation by IL-22
Mizoguchi, A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22929 · Cited by 152
Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
Kuwada, T., Shiokawa, M., Kodama, Y., Ota, S., Kakiuchi, N., Nannya, Y., Yamazaki, H., Yoshida, H., Nakamura, T., Matsumoto, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.019 · Cited by 145
Eftychi, C., Schwarzer, R., Vlantis, K., Wachsmuth, L., Basic, M., Wagle, P., Neurath, M. F., Becker, C., Bleich, A., & Pasparakis, M. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.008 · Cited by 129
Kobayashi, T., Suzuki, Y., Motoya, S., Hirai, F., Ogata, H., Ito, H., Sato, N., Ozaki, K., Watanabe, M., & Hibi∥, T. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1102-z · Cited by 118
Self-citationToedter, G. P., Li, K., Marano, C. W., Ma, K., Sague, S. L., Huang, C. C., Song, X.-Y., Rutgeerts, P. J., & Baribaud, F. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.83 · Cited by 116
Boehm, F., Martin, M. P., Kesselring, R., Schiechl, G., Geissler, E. K., Schlitt, H. J., & Fichtner‐Feigl, S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-97 · Cited by 99
IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation
Peng, J., Yang, X. O., Chang, S. H., Yang, J., & Dong, C. (2009) · Cell Research · doi:10.1038/cr.2009.128 · Cited by 94
Rismo, R., Olsen, T., Cui, G., Christiansen, I., Florholmen, J., & Goll, R. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.667146 · Cited by 82
Verstockt, B., Verstockt, S., Veny, M., Dehairs, J., Arnauts, K., Assche, G. V., Hertogh, G. D., Vermeire, S., Salas, A., & Ferrante, M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.030 · Cited by 78
Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis
Fichtner‐Feigl, S., Strober, W., Geissler, E. K., & Schlitt, H. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.41 · Cited by 70
Telesco, S., Brodmerkel, C., Zhang, H.-Y., Kim, L., Johanns, J., Mazumder, A., Li, K., Baribaud, F., Curran, M., Strauss, R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.077 · Cited by 64
Genetic characteristics of inflammatory bowel disease in a Japanese population
Fuyuno, Y., Yamazaki, K., Takahashi, A., Esaki, M., Kawaguchi, T., Takazoe, M., Matsumoto, T., Matsui, T., Tanaka, H., Motoya, S., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1135-3 · Cited by 60
Update: Innate Lymphoid Cells in Inflammatory Bowel Disease
Luo, W., Tian, L., Tan, B., Shen, Z., Xiao, M., Wu, S., Meng, X., Wu, X., & Wang, X. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06831-8 · Cited by 60
Collett, A., Higgs, N. B., Gironella, M., Zeef, L. A. H., Hayes, A., Salmo, E., Haboubi, N. Y., Iovanna, J., Carlson, G., & Warhurst, G. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20375 · Cited by 58
Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK
Baraldo, S., Faffe, D. S., Moore, P. E., Whitehead, T. R., McKenna, M. D., Silverman, E. S., Panettieri, R. A., & Shore, S. A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2002 · Cited by 56
Fitzpatrick, L. R. (2012) · International Journal of Inflammation · doi:10.1155/2012/389404 · Cited by 52
Pearl, D. S., Shah, K., Whittaker, M. A., Nitch‐Smith, H., Brown, J. F., Shute, J. K., & Trebble, T. M. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.07.022 · Cited by 49
Butera, A., Paola, M. D., Vitali, F., Nitto, D. D., Covotta, F., Borrini, F., Pica, R., Filippo, C. D., Cavalieri, D., Giuliani, A., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz154 · Cited by 45
Yamamoto, T., Saniabadi, A. R., Umegae, S., & Matsumoto, K. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00008 · Cited by 44
Iboshi, Y., Nakamura, K., Fukaura, K., Iwasa, T., Ogino, H., Sumida, Y., Ihara, E., Akiho, H., Harada, N., & Nakamuta, M. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1221-1 · Cited by 39
Chapuy, L., Bsat, M., Rubio, M., Sarkizova, S., Therrien, A., Bouin, M., Orlicka, K., Weber, A. M., Soucy, G., Villani, A., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz115 · Cited by 39
Schulz-Kuhnt, A., Neurath, M. F., Wirtz, S. J., & Atreya, I. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.656745 · Cited by 39
Lord, J. D., Long, S. A., Shows, D. M., Thorpe, J., Schwedhelm, K., Chen, J., Kita, M., & Buckner, J. H. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.05.006 · Cited by 38
Suzuki, T., Sasahara, Y., Kikuchi, A., Kakuta, H., Kashiwabara, T., Ishige, T., Nakayama, Y., Tanaka, M., Hoshino, A., Kanegane, H., et al. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0339-5 · Cited by 37
Okada, T., Kanda, T., Ueda, N., Ikebuchi, Y., Hashiguchi, K., Nakao, K., & Isomoto, H. (2020) · Biomedical Reports · doi:10.3892/br.2020.1280 · Cited by 32
Treatment of inflammatory bowel disease from the immunological perspective
Nakase, H. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1751934 · Cited by 32
Self-citationBaird, A., Mallon, D., Radford‐Smith, G. L., Boyer, J., Piche, T., Prescott, S. L., Lawrance, I. C., & Tulić, M. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9104 · Cited by 27
Mavroudis, G., Magnusson, M. K., Isaksson, S., Sundin, J., Simrén, M., Öhman, L., & Strid, H. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz072 · Cited by 27
Obraztsov, I. V., Широких, К. Е., Исааковна, О. О., Шапина, М. В., Wang, M., & Халиф, И. Л. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy358 · Cited by 24
Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block
Fiorino, G., Allocca, M., Correale, C., Roda, G., Furfaro, F., Loy, L., Zilli, A., Peyrin‐Biroulet, L., & Danese, S. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1727437 · Cited by 23
Soluble ligands as drug targets for treatment of inflammatory bowel disease
Tong, X., Zheng, Y., Li, Y., Xiong, Y., & Chen, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107859 · Cited by 18
Role of the IL-23-T-bet/GATA3 Axis for the Pathogenesis of Ulcerative Colitis
Ogino, H., Fukaura, K., Iboshi, Y., Nagamatsu, Y., Okuno, H., Nishioka, K., Nishihara, Y., Tanaka, Y., Chinen, T., Ihara, E., et al. (2020) · Inflammation · doi:10.1007/s10753-020-01358-y · Cited by 15
Cited by
Estevinho, M. M., Leão Moreira, P., Silva, I., Laranjeira Correia, J., Santiago, M., & Magro, F. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221142673 · Cited by 18
Metadata
- Authors
- Nakase, H., Sato, N., Mizuno, N., & Ikawa, Y.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 21
- Issue
- 3
- Pages
- 103017
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W4200100429
- Cited by
- 443
- References
- 73
- FWCI
- 25.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.